Literature DB >> 28962074

Study of pharmaceuticals in surface and wastewater from Cuernavaca, Morelos, Mexico: Occurrence and environmental risk assessment.

José Abraham Rivera-Jaimes1, Cristina Postigo2, Rosa María Melgoza-Alemán3, Jaume Aceña4, Damia Barceló5, Miren López de Alda4.   

Abstract

The present work describes the first known study to date on the occurrence of pharmaceuticals in surface water and wastewater of Cuernavaca, the capital of the state of Morelos (México). Selected pharmaceuticals (a total of 35) were extracted from the collected water samples with a generic solid phase extraction (SPE) protocol and determined in the sample extracts by means of high-performance liquid chromatography coupled to electrospray ionization-tandem mass spectrometry (HPLC-ESI-MS/MS). A screening level risk assessment combining the measured environmental concentrations (MECs) with dose-response data based on predicted no-effect concentrations (PNECs) was also applied to estimate Hazard Quotients (HQs) for the pharmaceuticals detected in the investigated area. A total of twelve pharmaceuticals were found in the water samples analyzed, with detection frequencies above 78% and in most cases of 100%. Overall, the most abundant pharmaceuticals in surface water were the analgesic and anti-inflammatory drugs naproxen (732-4880ng/L), acetaminophen (354-4460ng/L), and diclofenac (258-1398ng/L), and the lipid regulator bezafibrate (286-2100ng/L). On the contrary, other compounds like the β-blocker atenolol and the psychiatric drug carbamazepine were found at only a few ng or tens of ng per liter in the Apatlaco River. Despite the fact that some of the most abundant compounds showed good removal (>97%) during wastewater treatment, concentrations downstream the WWTP were only slightly lower than upstream. This indicates the existence of additional inputs of untreated wastewater into the river. Based on the obtained HQ-values, the concentrations of ibuprofen, sulfamethoxazole, diclofenac and naproxen present in the river could pose a high toxicity risk for the aquatic ecosystem. These findings highlight these pharmaceuticals as relevant organic contaminants in the area of study and the need to further monitor them in order to adopt appropriate measures to safeguard the ecosystem, and eventually human health.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drugs; Environmental impact; Liquid chromatography-tandem mass spectrometry; River water; Toxicity units; Wastewater treatment plants

Mesh:

Substances:

Year:  2017        PMID: 28962074     DOI: 10.1016/j.scitotenv.2017.09.134

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  11 in total

1.  Occurrence and Fate of Micropollutants in Private Wastewater Treatment Facility (WTF) and Their Impact on Receiving Water.

Authors:  Young-Min Kang; Moon-Kyung Kim; Taeyeon Kim; Tae-Kyoung Kim; Kyung-Duk Zoh
Journal:  Environ Manage       Date:  2019-10-12       Impact factor: 3.266

2.  Few-Layer MoS₂ Nanodomains Decorating TiO₂ Nanoparticles: A Case Study for the Photodegradation of Carbamazepine.

Authors:  Sara Cravanzola; Marco Sarro; Federico Cesano; Paola Calza; Domenica Scarano
Journal:  Nanomaterials (Basel)       Date:  2018-03-29       Impact factor: 5.076

3.  The use of RP-HPLC-Q-TOF-MS as a powerful tool for wastewater composition profiling and selection of water pollution marker specific to wastewater contamination.

Authors:  Dagmara Kempińska; Agata Kot-Wasik
Journal:  Monatsh Chem       Date:  2018-08-09       Impact factor: 1.451

4.  Features of diclofenac biodegradation by Rhodococcus ruber IEGM 346.

Authors:  Irina B Ivshina; Elena A Tyumina; Maria V Kuzmina; Elena V Vikhareva
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

5.  The role of urbanization in soil and groundwater contamination by heavy metals and pathogenic bacteria: A case study from Oman.

Authors:  Baby Shaharoona; Said Al-Ismaily; Ahmed Al-Mayahi; Nadhira Al-Harrasi; Ruqaiya Al-Kindi; Abdullah Al-Sulaimi; Hamad Al-Busaidi; Mohammed Al-Abri
Journal:  Heliyon       Date:  2019-05-27

Review 6.  Sample Preparation to Determine Pharmaceutical and Personal Care Products in an All-Water Matrix: Solid Phase Extraction.

Authors:  Daniele Sadutto; Yolanda Picó
Journal:  Molecules       Date:  2020-11-09       Impact factor: 4.411

Review 7.  Occurrence and fate of pharmaceuticals, personal care products (PPCPs) and pesticides in African water systems: A need for timely intervention.

Authors:  Charles Obinwanne Okoye; Emmanuel Sunday Okeke; Kingsley Chukwuebuka Okoye; Daniel Echude; Felix Attawal Andong; Kingsley Ikechukwu Chukwudozie; Henrietta Ukamaka Okoye; Chigozie Damian Ezeonyejiaku
Journal:  Heliyon       Date:  2022-03-18

8.  Design and application of molecularly imprinted polymers for adsorption and environmental assessment of anti-inflammatory drugs in wastewater samples.

Authors:  Jessica Meléndez-Marmolejo; Lorena Díaz de León-Martínez; Vanessa Galván-Romero; Samantha Villarreal-Lucio; Raúl Ocampo-Pérez; Nahum A Medellín-Castillo; Erika Padilla-Ortega; Israel Rodríguez-Torres; Rogelio Flores-Ramírez
Journal:  Environ Sci Pollut Res Int       Date:  2022-02-12       Impact factor: 5.190

9.  Carbamazepine and Diclofenac Removal Double Treatment: Oxidation and Adsorption.

Authors:  Alejandro Aldeguer Esquerdo; Pedro José Varo Galvañ; Irene Sentana Gadea; Daniel Prats Rico
Journal:  Int J Environ Res Public Health       Date:  2021-07-04       Impact factor: 3.390

10.  High-throughput multi-residue quantification of contaminants of emerging concern in wastewaters enabled using direct injection liquid chromatography-tandem mass spectrometry.

Authors:  Keng Tiong Ng; Helena Rapp-Wright; Melanie Egli; Alicia Hartmann; Joshua C Steele; Juan Eduardo Sosa-Hernández; Elda M Melchor-Martínez; Matthew Jacobs; Blánaid White; Fiona Regan; Roberto Parra-Saldivar; Lewis Couchman; Rolf U Halden; Leon P Barron
Journal:  J Hazard Mater       Date:  2020-05-24       Impact factor: 10.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.